DUKE CTSI: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA)

杜克 CTSI：最佳儿童药品法案 (BPCA)

• 批准号: 7961830
• 负责人: ROBERT M CALIFF
• 金额: $ 49.82万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7961830
• 关键词: Best Pharmaceuticals for Children Act

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This supplemental award provides funds to CTSA Consortium-supported research projects for research on outcome measures in clinical and translational child health in priority areas as determined by the Best Pharmaceuticals for Children Act (BPCA) program administered by NICHD.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 该补充奖项为CTSA财团支持的研究项目提供了资金，以研究优先领域的临床和转化儿童健康结果指标，这是由NICHD管理的最佳儿童法案（BPCA）计划确定的。